Context Therapeutics (CNTX) Interest & Investment Income (2024 - 2026)
Context Therapeutics' (CNTX) quarterly Interest & Investment Income came in at $520139.0 in Q1 2026, down 45.74% year-on-year from $958517.0 in Q1 2025, and down 23.79% quarter-over-quarter from $682484.0 in Q4 2025.
Context Therapeutics (CNTX) Interest & Investment Income (2024 - 2026) Analysis & Trends
Context Therapeutics has disclosed Interest & Investment Income across 3 years of filings, most recently posting $520139.0 for Q1 2026.
- Interest & Investment Income for Q1 2026 came in at $520139.0, down 45.74% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.9 million (down 26.61% YoY), and the FY2025 annual result was $3.4 million, up 5.57% from the prior year.
- Interest & Investment Income came in at $520139.0 for Q1 2026 at Context Therapeutics, down from $682484.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $1.2 million in Q3 2024 to a low of $152351.0 in Q1 2024.
- The 3-year median for Interest & Investment Income is $840150.0 (2024), against an average of $788767.6.
- Across the five-year window, Interest & Investment Income soared 529.15% in 2025 and sank 45.74% in 2026, its largest moves.
- Context Therapeutics' Interest & Investment Income stood at $964036.0 in 2024, then slipped by 29.21% to $682484.0 in 2025, then slipped by 23.79% to $520139.0 in 2026.
- The last three Interest & Investment Income figures came in at $520139.0 (Q1 2026), $682484.0 (Q4 2025), and $833772.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | 597,319.59 |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | 305,000.00 |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | -14.79 Mn |
| 10 | Context Therapeutics | 166.57 Mn | 166.57 Mn | - | 520,139.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 520,139.00 |
| Dec 31, 2025 | 682,484.00 |
| Sep 30, 2025 | 833,772.00 |
| Jun 30, 2025 | 903,772.00 |
| Mar 31, 2025 | 958,517.00 |
| Dec 31, 2024 | 964,036.00 |
| Sep 30, 2024 | 1.24 Mn |
| Jun 30, 2024 | 840,150.00 |
| Mar 31, 2024 | 152,351.00 |